Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial intelligence in sickle disease
19
Zitationen
13
Autoren
2023
Jahr
Abstract
Artificial intelligence (AI) is rapidly becoming an established arm in medical sciences and clinical practice in numerous medical fields. Its implications have been rising and are being widely used in research, diagnostics, and treatment options for many pathologies, including sickle cell disease (SCD). AI has started new ways to improve risk stratification and diagnosing SCD complications early, allowing rapid intervention and reallocation of resources to high-risk patients. We reviewed the literature for established and new AI applications that may enhance management of SCD through advancements in diagnosing SCD and its complications, risk stratification, and the effect of AI in establishing an individualized approach in managing SCD patients in the future. Aim: to review the benefits and drawbacks of resources utilizing AI in clinical practice for improving the management for SCD cases.
Ähnliche Arbeiten
Automatic Recording Apparatus for Use in Chromatography of Amino Acids
1958 · 9.602 Zit.
Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia
1985 · 8.998 Zit.
Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent
1968 · 7.957 Zit.
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
2004 · 4.725 Zit.
A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis
1996 · 3.706 Zit.